Cargando…
OR26-1 Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem-Like and Proliferative Breast Cancer Cell Fates
Progesterone receptors (PRs) are key modifiers of ER target gene selection and drivers of luminal breast cancer progression. In addition to Her2 and estrogen receptor (ER), total PRs rather than isoform-specific PR expression levels are measured in breast tumors as indicators of functional ER. Herei...
Autores principales: | Truong, Thu, Dwyer, Amy, Diep, Caroline, Lange, Carol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554919/ http://dx.doi.org/10.1210/js.2019-OR26-1 |
Ejemplares similares
-
SUN-004 Unique Cell Fates and Metastatic Phenotypes Are Activated by Progesterone Receptor (PR) Isoform-specific Gene Expression in Fallopian Tube Models of HGSC
por: Seibel, Megan, et al.
Publicado: (2019) -
Differential Genomic Interactions Drive Progesterone Receptor Isoform Specific Functions in Breast Cancer
por: Doan, Tram B, et al.
Publicado: (2021) -
SUN-742 Roles of Progesterone Receptor Isoform B in Non-Small Cell Lung Cancer Tumor Progression
por: Asavasupreechar, Teeranut, et al.
Publicado: (2020) -
SUN-007 Discovery of Novel Signaling Pathways Downstream of PTK6 in TNBC Models
por: Dwyer, Amy, et al.
Publicado: (2019) -
THU570 Isoform Specific Gene Regulation By Progesterone Receptors Drives Expansion Of Breast Cancer Stem Cell Expansion In 3D Cell Culture Models
por: Gillis, Noelle E, et al.
Publicado: (2023)